Antimicrobial and antifungal activity of some (5-(adamantane-1-yl)-4R-1,2,4-triazole-3-ylthiols substitutes
DOI:
https://doi.org/10.14739/2409-2932.2016.3.77945Keywords:
1, 2, 4-triazole, Adamantane, Anti-Bacterial Agents, Antifungal AgentsAbstract
Lately adamantine containing substances have found wide use among the skeleton derivatives. The combination of adamantane and 1,2,4-triazole in one molecule creates significant preconditions to design new potential drugs with low toxicity and pronounced pharmacological activity.
The aim of the research is the study of antimicrobial and antifungal activity of (5-(adamantane-1-yl)-4-R-1,2,4-triazole-3-ylthiols substitutes.
Materials and methods. Determination of antimicrobial and antifungal activity has been carried out by 2-fold serial dilutions method in liquid nutrient media.
The substance of the antibacterial drug Trimethoprim has been applied as a control in determining antimicrobial activity of the compounds against the investigated strains of microorganisms.
Results. According to the data of experiments the 5-(((5-(adamantane-1-yl)-4-ethyl-4H-1,2,4-triazole-3-yl)thio)methyl)-4-ethyl-4H-1,2,4-triazole-3-thiol shows the same activity as Trimethoprim against P. aeruginosa (MIC is 62.5 µg/ml, MBC – 125 μg/ml), marked activity towards S. aureus (MIC is 15.6 μg/ml, MBC – 31.25 μg/ml while trimethoprim – 31.25 μg/ml, MBC – 62.5 µg/ml), greater fungistatic and fungicidal activity towards C. albicans, which amounted to 31.25 µg/ml, MFC – 62.5 µg/ml (while trimethoprim 62.5 µg/ml, MFC – 125 µg/ml).
Reconstration of benzyldenhydrazide group to hydrazide one leads to the slight increase of bacteriostatic activity. Replacing the radical R from -Н to -C2H5 does not influence on the change of fungistatic activity. However, this resulted to the decrease in bacteriostatic activity against E. coli. The same is observed in relation to P. aeruginosa: from 62.5 μg/ml, MFC – 125 mcg/ml to 125 μg/ml, MFC – 125 µg/m respectively.
Conclusion. The conducted study has showed that among the synthesized compounds there are some substances which strength of the antimicrobial and antifungal action in some cases exceeds the standard of comparison - Trimethoprim.
The most active compound against the test strain of C. albicans was 2-(5-(((5-(adamantane-1-yl)-4H-1,2,4-triazole-3-yl)thio)methyl)-1,3,4-thiodiazole(todosol)-2-amine), which activity in 8 times higher than the standard of comparison.
The study of biological and pharmacological activity of the synthesized compounds, and also the determination of the regularities between structure and activity create a favorable basis for the search of new medicines in a number of 1,2,4-triazole derivatives.
References
Kovalenko, V. N. (2015) Kompendium 2015 – lekarstvyennye preparaty [Compendium 2015 – drugs]. – Kyiv: МОRIОN. [in Ukrainan].
Bilyi, A. K., Kovalenko, S. I., Antipenko, L. M., Kamyshnyi, O. M., & Polishchuk, N. M. (2013) Protyhrybkova ta protymikrobna aktyvnist {2-[3-heteryl-1N-1,2,4-triazol-5-il]fenil}aminiv i produktiv yikh heterotsyklizatsii [Antifungal and antimicrobial activity of {2-[3-heteryl-1H-1,2,4-triazole-5-yl]phenyl}amine and products of their heterocyclization]. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 2(12), 80–82. [in Ukrainan].
Shalini, K., Kumar, N., Drabu, S., & Sharma, P.K. (2011). Advances in synthetic approach to and antifungal activity of triazoles. J. Org. Chem., 7, 668–677. doi: 10.3762/bjoc.7.79.
Jacob, J. H., Irshaid, F. I., & Al-Soud, Y. A. (2013) Antibacterial activity of some selected 1,2,4-triazole derivatives against standard, environmental, and medical bacterial strains. Advanced Studies in Biology., 5(6), 291–301. http://dx.doi.org/10.12988/asb.2013.3418.
El-Sayed, W. A., Flefel, E. M., & Morsy, E. M. H. (2012) Anticancer and antimicrobial activities of some synthesized pyrazole and triazolederivatives. Der Pharma Chemica., 4(1), 23–32.
Calu, L., Badea, M., Falcescu, D., Duca, D., Marinescu, D., & Olar, R. (2013) Thermal study on complexes with Schiff base derived from 1,2,4-triazole as potential antimicrobial agents. J. Thermal Analysis and Calorimetry., 111(3), 1725–1730. doi: 10.1007/s10973-012-2201-1.
Chai, X., Yu, S., Jiang, Y., Zou, Y., Wu, Q., Zhang, D. et al. (2012) Design, synthesis and biological evaluation of novel 1,2,4-triazole derivatives as antifungal agent. Arch. Pharmacol. Res., 35(11), 1895–1901. doi:10.1007/s12272-012-1105-8.
Patil, B. S., Krishnamurthy, G., Lokesh, M. R., Shashikumar, N. D., Bhojya Naik, H. S., Latthe, P. R., & Ghate, M. (2013) Synthesis of some novel 1,2,4-triazole and 1,3,4-oxadizole derivatives of biological interest. Med. Chem. Res., 22(7), 3341–3349. doi:10.1007/s00044-012-0332-3.
Popiołek, Ł., Kosikowska, U., Mazur, L., Dobosz, M., & Malm, A. (2013) Synthesis and antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Med. Chem. Res., 22(7), 3134–3147. doi:10.1007/s00044-012-0302-9.
Tang, R., Jin, L., Mou, C., Yin, J., Bai, S., Hu, D., et al. (2013) Synthesis, antifungal and antibacterial activity for novel amide derivatives containing a triazolemoiety. Chemistry Central Journal, 7(30), 1–7. doi: 10.1186/1752-153X-7-30.
Desai, Sh., Laddi, U., Bennur, R., & Bennur, Sh. (2013) Synthesis and antimicrobial activities of some new 1,2,4-triazole derivatives. Indian Journal of Chemistry, 52(08), 1176–1181.
Morozov, Y. S., Petrov, V. I., & Sergeeva, S. A. (2001) Farmakologiya adamantanov [The Pharmacology of adamantanes]. Volgograd. [in Russian].
Volianskyi, Yu. L., Hrytsenko, I. S., Shyrobokov, V. P., et al. (2004) Vyvchennia spetsyfichnoi aktyvnosti protymikrobnykh likarskykh zasobiv [Studying of the specific activity of antimicrobial drugs]. Kyiv. [in Ukrainian].
Nakaz MOZ Ukrainy «Pro zatverdzhennia metodychnykh vkazivok «Vyznachennia chutlyvosti mikroorhanizmiv do antybakterialnykh preparativ»» vid 05.04.2007 p. №167 [HPM Ukraine order «About approval guidelines «Determination of the sensitivity of microorganisms to antibiotics»» from April, 05, 2007, №167]. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
